212 related articles for article (PubMed ID: 32446809)
1. Association of drinking water and migraine headache severity.
Khorsha F; Mirzababaei A; Togha M; Mirzaei K
J Clin Neurosci; 2020 Jul; 77():81-84. PubMed ID: 32446809
[TBL] [Abstract][Full Text] [Related]
2. Association of dietary diversity score (DDS) and migraine headache severity among women.
Khorsha F; Mirzababaei A; Togha M; Mirzaei K
Neurol Sci; 2021 Aug; 42(8):3403-3410. PubMed ID: 33428056
[TBL] [Abstract][Full Text] [Related]
3. Associations between adherence to dietary approaches to stop hypertension (DASH) diet and migraine headache severity and duration among women.
Mirzababaei A; Khorsha F; Togha M; Yekaninejad MS; Okhovat AA; Mirzaei K
Nutr Neurosci; 2020 May; 23(5):335-342. PubMed ID: 30064351
[No Abstract] [Full Text] [Related]
4. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire.
Iigaya M; Sakai F; Kolodner KB; Lipton RB; Stewart WF
Headache; 2003 Apr; 43(4):343-52. PubMed ID: 12656705
[TBL] [Abstract][Full Text] [Related]
5. Use of the Migraine Disability Assessment Questionnaire in children and adolescents with headache: an Italian pilot study.
D'Amico D; Grazzi L; Usai S; Andrasik F; Leone M; Rigamonti A; Bussone G
Headache; 2003; 43(7):767-73. PubMed ID: 12890131
[TBL] [Abstract][Full Text] [Related]
6. The association between adherence to alternative healthy Diet Index (AHEI) and severity, disability, duration, and frequency of migraine headache among women: a cross-sectional study.
Khalili P; Mirzababaei A; Abaj F; Ansari S; Harsini AR; Hajmir MM; Clark CCT; Mirzaei K
Nutr J; 2023 Aug; 22(1):41. PubMed ID: 37612713
[TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
[TBL] [Abstract][Full Text] [Related]
8. Need for care and perceptions of MIDAS among headache sufferers study.
Stewart W; Lipton R
CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
10. Headache-related disability among medical students in Amazon: a cross-sectional study.
Almeida CM; Lima PA; Stabenow R; Mota RS; Boechat AL; Takatani M
Arq Neuropsiquiatr; 2015 Dec; 73(12):1009-13. PubMed ID: 26677121
[TBL] [Abstract][Full Text] [Related]
11. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Spanish version of the migraine disability assessment questionnaire (MIDAS) in university students with migraine.
Rodríguez-Almagro D; Achalandabaso A; Rus A; Obrero-Gaitán E; Zagalaz-Anula N; Lomas-Vega R
BMC Neurol; 2020 Feb; 20(1):67. PubMed ID: 32093620
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates of insomnia in patients with persistent post-traumatic headache compared with migraine.
Kim SK; Chong CD; Dumkrieger G; Ross K; Berisha V; Schwedt TJ
J Headache Pain; 2020 Apr; 21(1):33. PubMed ID: 32295535
[TBL] [Abstract][Full Text] [Related]
15. MIDAS and HIT-6 French translation: reliability and correlation between tests.
Magnoux E; Freeman MA; Zlotnik G
Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
[TBL] [Abstract][Full Text] [Related]
16. Validity of an illness severity measure for headache in a population sample of migraine sufferers.
Stewart WF; Lipton RB; Simon D; Liberman J; Von Korff M
Pain; 1999 Feb; 79(2-3):291-301. PubMed ID: 10068175
[TBL] [Abstract][Full Text] [Related]
17. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.
Stewart WF; Lipton RB; Dowson AJ; Sawyer J
Neurology; 2001; 56(6 Suppl 1):S20-8. PubMed ID: 11294956
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
19. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers.
Stewart WF; Lipton RB; Kolodner KB; Sawyer J; Lee C; Liberman JN
Pain; 2000 Oct; 88(1):41-52. PubMed ID: 11098098
[TBL] [Abstract][Full Text] [Related]
20. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.
Stewart WF; Lipton RB; Whyte J; Dowson A; Kolodner K; Liberman JN; Sawyer J
Neurology; 1999 Sep; 53(5):988-94. PubMed ID: 10496257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
